Improving lung cancer survival; time to move on

Por Heuvers, Marlies E, Hegmans, Joost P, Stricker, Bruno H, Aerts, Joachim G
Publicado em 2012

Immunotherapy prospects in the treatment of lung cancer and mesothelioma

Por Aerts, Joachim G., Lievense, Lysanne A., Hoogsteden, Henk C., Hegmans, Joost P.
Publicado no Transl Lung Cancer Res (2014)

Patient-tailored modulation of the immune system may revolutionize future lung cancer treatment

Por Heuvers, Marlies E, Aerts, Joachim G, Cornelissen, Robin, Groen, Harry, Hoogsteden, Henk C, Hegmans, Joost P
Publicado em 2012

Tumour-derived exosomes as antigen delivery carriers in dendritic cell-based immunotherapy for malignant mesothelioma

Por Mahaweni, Niken M., Kaijen-Lambers, Margaretha E.H., Dekkers, Jacqueline, Aerts, Joachim G.J.V., Hegmans, Joost P.J.J.
Publicado em 2013

Ratio of Intratumoral Macrophage Phenotypes Is a Prognostic Factor in Epithelioid Malignant Pleural Mesothelioma

Por Cornelissen, Robin, Lievense, Lysanne A., Maat, Alexander P., Hendriks, Rudi W., Hoogsteden, Henk C., Bogers, Ad J., Hegmans, Joost P., Aerts, Joachim G.
Publicado em 2014

Low-Dose Cyclophosphamide Synergizes with Dendritic Cell-Based Immunotherapy in Antitumor Activity

Por Veltman, Joris D., Lambers, Margaretha E. H., van Nimwegen, Menno, de Jong, Sanne, Hendriks, Rudi W., Hoogsteden, Henk C., Aerts, Joachim G. J. V., Hegmans, Joost P. J. J.
Publicado em 2010

Proteomic Analysis of Exosomes Secreted by Human Mesothelioma Cells

Por Hegmans, Joost P.J.J., Bard, Martin P.L., Hemmes, Annabrita, Luider, Theo M., Kleijmeer, Monique J., Prins, Jan-Bas, Zitvogel, Laurence, Burgers, Sjaak A., Hoogsteden, Henk C., Lambrecht, Bart N.
Publicado em 2004